Carna Biosciences Inc (4572):企業の財務・戦略的SWOT分析

◆英語タイトル:Carna Biosciences Inc (4572) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82659FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive-mutant kinases, pre-selected panels, crystal grade proteins, and ready to use products to study kinases-molecule interactions, among others. Its kinase proteins include cytoplasmic tyrosine kinases, receptor tyrosine kinases, lipid kinases, serine and threonine kinases, among others. Carna offers services such as RPPA cell signaling analysis service, tyrosine kinase cell-based assay, co-crystallography, assay development and profiling services. The company serves its clients across Japan. Carna is headquartered in Kobe, Japan.

Carna Biosciences Inc Key Recent Developments

Feb 01,2021: Open Orphan: Contract extension with Carna Biosciences
Aug 04,2020: Open Orphan: New contract win with Carna Bioscience

This comprehensive SWOT profile of Carna Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Carna Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Carna Biosciences Inc – Key Information
Carna Biosciences Inc – Overview
Carna Biosciences Inc – Key Employees
Carna Biosciences Inc – Key Employee Biographies
Carna Biosciences Inc – Key Operational Heads
Carna Biosciences Inc – Major Products and Services
Carna Biosciences Inc – History
Carna Biosciences Inc – Company Statement
Carna Biosciences Inc – Locations And Subsidiaries
Carna Biosciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Carna Biosciences Inc – Business Description
Carna Biosciences Inc – Corporate Strategy
Carna Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Carna Biosciences Inc – Strengths
Carna Biosciences Inc – Weaknesses
Carna Biosciences Inc – Opportunities
Carna Biosciences Inc – Threats
Carna Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Carna Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Carna Biosciences Inc, Key Information
Carna Biosciences Inc, Key Ratios
Carna Biosciences Inc, Share Data
Carna Biosciences Inc, Major Products and Services
Carna Biosciences Inc, History
Carna Biosciences Inc, Key Employees
Carna Biosciences Inc, Key Employee Biographies
Carna Biosciences Inc, Key Operational Heads
Carna Biosciences Inc, Other Locations
Carna Biosciences Inc, Subsidiaries
Carna Biosciences Inc, Key Competitors
Carna Biosciences Inc, SWOT Analysis
Carna Biosciences Inc, Ratios based on current share price
Carna Biosciences Inc, Annual Ratios
Carna Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Carna Biosciences Inc (4572):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atlas Copco AB (ATCO A):石油・ガス:M&Aディール及び事業提携情報
    Summary Atlas Copco AB (Atlas Copco) is a provider of industrial productivity solutions. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. The company’s products include vacuum solutions and air tr …
  • Bank Sinopac:企業の戦略・SWOT・財務分析
    Bank Sinopac - Strategy, SWOT and Corporate Finance Report Summary Bank Sinopac - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Delphi Financial Group, Inc.:企業の戦略・SWOT・財務情報
    Delphi Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Delphi Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Altium Ltd:企業の戦略・SWOT・財務分析
    Altium Ltd - Strategy, SWOT and Corporate Finance Report Summary Altium Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Panasonic Homes Co., Ltd.:企業の戦略的SWOT分析
    Panasonic Homes Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sophiris Bio Inc (SPHS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sophiris Bio Inc (Sophiris) is a clinical stage bio-pharmaceutical company, which focuses on developing products for the treatment of urological diseases. Sophiris lead drug candidate, PRX302 is under late stage development for the treatment of lower urinary tract symptoms of benign prostati …
  • Frigo Pak Gida Maddeleri Sanayi ve Tic.:企業の戦略・SWOT・財務分析
    Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report Summary Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Caspian Energy Inc. (CKZ.H)-石油・ガス分野:企業M&A・提携分析
    Summary Caspian Energy Inc. (Caspian) is an independent upstream oil and gas company that explores for and develops hydrocarbon reserves, and produces oil and gas. Caspian and its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license which entitles it to explore …
  • POSCO:企業の戦略・SWOT・財務情報
    POSCO - Strategy, SWOT and Corporate Finance Report Summary POSCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Charoen Pokphand Foods Public Co Ltd (CPF):企業の財務・戦略的SWOT分析
    Charoen Pokphand Foods Public Co Ltd (CPF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Nestle SA:企業の戦略・SWOT・財務情報
    Nestle SA - Strategy, SWOT and Corporate Finance Report Summary Nestle SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • GIZEH Raucherbedarf GmbH:企業の戦略的SWOT分析
    GIZEH Raucherbedarf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • 1-800-FLOWERS.COM Inc (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM Inc (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Arion Bank hf.:企業の戦略・SWOT・財務情報
    Arion Bank hf. - Strategy, SWOT and Corporate Finance Report Summary Arion Bank hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • FOX Broadcasting Co:企業の戦略的SWOT分析
    FOX Broadcasting Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Easywell Biomedical Inc (1799)-医療機器分野:企業M&A・提携分析
    Summary Easywell Biomedical Inc (Easywell), formerly Actherm Inc is a health care company that offers medical devices and testing devices. The company offers pharmaceuticals, regenerative medicines and medical devices, among others. Its medical devices comprise pain management systems, non-contact, …
  • ImmunoCellular Therapeutics Ltd (IMUC):医療機器:M&Aディール及び事業提携情報
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Geisinger:医療機器:M&Aディール及び事業提携情報
    Summary Geisinger formerly, Geisinger Health System is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers medical services for patients related to cardiology, ENT, gastroenterology, gynecology, cancer, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆